Arax Advisory Partners’s HUTCHMED HCM Stock Holding History

Arax Advisory Partners’s Portfolio HCM Stock Details HCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.3K	Buy	400 +297	+288%	+$3.76K	﹤0.01%	4636
2026 Q1	$1.54K	Hold	103	–	–	﹤0.01%	3182
2025 Q4	$1.37K	Sell	103 -103	-50%	-$1.5K	﹤0.01%	3399
2025 Q3	$3.25K	Buy	206 +103	+100%	+$1.7K	﹤0.01%	2993
2025 Q2	$1.55K	Hold	103	–	–	﹤0.01%	2648
2025 Q1	$1.55K	Hold	103	–	–	﹤0.01%	2153
2024 Q4	$1.49K	Hold	103	–	–	﹤0.01%	2080
2024 Q3	$2.01K	Hold	103	–	–	﹤0.01%	2065
2024 Q2	$1.76K	Hold	103	–	–	﹤0.01%	2010
2024 Q1	$1.73K	Hold	103	–	–	﹤0.01%	1060
2023 Q4	$1.87K	Hold	103	–	–	﹤0.01%	1029
2023 Q3	$1.75K	Hold	103	–	–	﹤0.01%	1037
2023 Q2	$1.24K	Hold	103	–	–	﹤0.01%	1076
2023 Q1	$1.34K	Hold	103	–	–	﹤0.01%	1051
2022 Q4	$1.52K	Hold	103	–	–	﹤0.01%	986
2022 Q3	$1K	Sell	103 -15	-13%	-$189	﹤0.01%	1082
2022 Q2	$1K	Buy	118 +60	+103%	+$764	﹤0.01%	1050
2022 Q1	$1K	Buy	58 +22	+61%	+$560	﹤0.01%	1037
2021 Q4	$1K	Buy	36 +21	+140%	+$682	﹤0.01%	1017
2021 Q3	$1K	Buy	+15	New	+$590	﹤0.01%	908

Other funds holding HCM

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AIA Group Hong Kong $7.95B AUM 28.94% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

XY Capital Central, Hong Kong $104M AUM 8% 1-Year Est. Return

Arax Advisory Partners's HCM Position: Q2 2026 in Review

Arax Advisory Partners increased its HUTCHMED (HCM) stake by 288% in Q2 2026, buying an estimated $3.76K and bringing the position to 400 shares worth $4.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4636.

Arax Advisory Partners first reported a position in HCM in Q3 2021 and has held it in 20 quarters since. 56 funds tracked by Wall St. Rank hold HCM as of Q2 2026.

Arax Advisory Partners held 400 shares of HUTCHMED worth $4.3K as of Q2 2026.
Arax Advisory Partners bought 297 HUTCHMED shares in Q2 2026, an estimated $3.76K.
HUTCHMED made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4636 holding.
Arax Advisory Partners first reported a position in HUTCHMED in Q3 2021 and has held it in 20 quarters since.
56 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.